Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity

Silymarin extracted from milk thistle consisting of flavonolignan silybin has shown chemopreventive and chemosensitizing activity against various cancers. The present review summarizes the current knowledge on the potential targets of silymarin against various cancers. Silymarin may play on the syst...

Full description

Bibliographic Details
Main Authors: Dominique Delmas, Jianbo Xiao, Anne Vejux, Virginie Aires
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/9/2009
_version_ 1827718021265752064
author Dominique Delmas
Jianbo Xiao
Anne Vejux
Virginie Aires
author_facet Dominique Delmas
Jianbo Xiao
Anne Vejux
Virginie Aires
author_sort Dominique Delmas
collection DOAJ
description Silymarin extracted from milk thistle consisting of flavonolignan silybin has shown chemopreventive and chemosensitizing activity against various cancers. The present review summarizes the current knowledge on the potential targets of silymarin against various cancers. Silymarin may play on the system of xenobiotics, metabolizing enzymes (phase I and phase II) to protect normal cells against various toxic molecules or to protect against deleterious effects of chemotherapeutic agents on normal cells. Furthermore, silymarin and its main bioactive compounds inhibit organic anion transporters (OAT) and ATP-binding cassettes (ABC) transporters, thus contributing to counteracting potential chemoresistance. Silymarin and its derivatives play a double role, namely, limiting the progression of cancer cells through different phases of the cycle—thus forcing them to evolve towards a process of cell death—and accumulating cancer cells in a phase of the cell cycle—thus making it possible to target a greater number of tumor cells with a specific anticancer agent. Silymarin exerts a chemopreventive effect by inducing intrinsic and extrinsic pathways and reactivating cell death pathways by modulation of the ratio of proapoptotic/antiapoptotic proteins and synergizing with agonists of death domains receptors. In summary, we highlight how silymarin may act as a chemopreventive agent and a chemosensitizer through multiple pathways.
first_indexed 2024-03-10T20:13:44Z
format Article
id doaj.art-8739fac32f0e4ac5abf3037b595eaac0
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T20:13:44Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-8739fac32f0e4ac5abf3037b595eaac02023-11-19T22:43:11ZengMDPI AGMolecules1420-30492020-04-01259200910.3390/molecules25092009Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and ChemosensitivityDominique Delmas0Jianbo Xiao1Anne Vejux2Virginie Aires3Université de Bourgogne Franche-Comté, F-21000 Dijon, FranceInternational Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang 212013, ChinaUniversité de Bourgogne Franche-Comté, F-21000 Dijon, FranceUniversité de Bourgogne Franche-Comté, F-21000 Dijon, FranceSilymarin extracted from milk thistle consisting of flavonolignan silybin has shown chemopreventive and chemosensitizing activity against various cancers. The present review summarizes the current knowledge on the potential targets of silymarin against various cancers. Silymarin may play on the system of xenobiotics, metabolizing enzymes (phase I and phase II) to protect normal cells against various toxic molecules or to protect against deleterious effects of chemotherapeutic agents on normal cells. Furthermore, silymarin and its main bioactive compounds inhibit organic anion transporters (OAT) and ATP-binding cassettes (ABC) transporters, thus contributing to counteracting potential chemoresistance. Silymarin and its derivatives play a double role, namely, limiting the progression of cancer cells through different phases of the cycle—thus forcing them to evolve towards a process of cell death—and accumulating cancer cells in a phase of the cell cycle—thus making it possible to target a greater number of tumor cells with a specific anticancer agent. Silymarin exerts a chemopreventive effect by inducing intrinsic and extrinsic pathways and reactivating cell death pathways by modulation of the ratio of proapoptotic/antiapoptotic proteins and synergizing with agonists of death domains receptors. In summary, we highlight how silymarin may act as a chemopreventive agent and a chemosensitizer through multiple pathways.https://www.mdpi.com/1420-3049/25/9/2009silymarinsilybinchemopreventivechemosensitizerABC transportercell cycle
spellingShingle Dominique Delmas
Jianbo Xiao
Anne Vejux
Virginie Aires
Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity
Molecules
silymarin
silybin
chemopreventive
chemosensitizer
ABC transporter
cell cycle
title Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity
title_full Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity
title_fullStr Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity
title_full_unstemmed Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity
title_short Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity
title_sort silymarin and cancer a dual strategy in both in chemoprevention and chemosensitivity
topic silymarin
silybin
chemopreventive
chemosensitizer
ABC transporter
cell cycle
url https://www.mdpi.com/1420-3049/25/9/2009
work_keys_str_mv AT dominiquedelmas silymarinandcanceradualstrategyinbothinchemopreventionandchemosensitivity
AT jianboxiao silymarinandcanceradualstrategyinbothinchemopreventionandchemosensitivity
AT annevejux silymarinandcanceradualstrategyinbothinchemopreventionandchemosensitivity
AT virginieaires silymarinandcanceradualstrategyinbothinchemopreventionandchemosensitivity